Potential Risks of Combining Intermittent Fasting and GLP-1s Pairing GLP-1 medications with intermittent fasting can be a great way to amplify weight loss and metabolic benefits, but you have to do it correctly
Research suggests that GIP also improves fat utilization, encouraging the body to burn more fat for energy rather than storing it
Semaglutide is a GLP-1 receptor agonist primarily used as a treatment for diabetes (Ozempic, Novo Nordisk) and more recently greenlit as a breakthrough treatment for obesity (Wegovy, Novo Nordisk)
Lipotropic B12 injections, while more gradual, support steady weight loss by boosting metabolism and energy levels
The treatment helped clear my skin tone and reduced the patchy look
The first GLP-1 medication (liraglutide) was only approved in 2014, and semaglutide wasnt approved until 2017